AP3547A - Process for preparation of optically pure and optionally substituted 2- (1 -hydroxy- alkyl) - chromen - 4 - one derivatives and their use in preparing pharmaceuticals - Google Patents
Process for preparation of optically pure and optionally substituted 2- (1 -hydroxy- alkyl) - chromen - 4 - one derivatives and their use in preparing pharmaceuticalsInfo
- Publication number
- AP3547A AP3547A AP2014008087A AP2014008087A AP3547A AP 3547 A AP3547 A AP 3547A AP 2014008087 A AP2014008087 A AP 2014008087A AP 2014008087 A AP2014008087 A AP 2014008087A AP 3547 A AP3547 A AP 3547A
- Authority
- AP
- ARIPO
- Prior art keywords
- chromen
- hydroxy
- derivatives
- alkyl
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
- C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
- C07D311/34—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only
- C07D311/36—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only not hydrogenated in the hetero ring, e.g. isoflavones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
- C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1737CH2012 | 2012-05-04 | ||
US201261671956P | 2012-07-16 | 2012-07-16 | |
PCT/IB2013/053544 WO2013164801A1 (en) | 2012-05-04 | 2013-05-03 | Process for preparation of optically pure and optionally substituted 2- (1 -hydroxy- alkyl) - chromen - 4 - one derivatives and their use in preparing pharmaceuticals |
Publications (2)
Publication Number | Publication Date |
---|---|
AP2014008087A0 AP2014008087A0 (en) | 2014-11-30 |
AP3547A true AP3547A (en) | 2016-01-14 |
Family
ID=54193684
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AP2014008087A AP3547A (en) | 2012-05-04 | 2013-05-03 | Process for preparation of optically pure and optionally substituted 2- (1 -hydroxy- alkyl) - chromen - 4 - one derivatives and their use in preparing pharmaceuticals |
Country Status (25)
Country | Link |
---|---|
US (1) | US9309216B2 (pl) |
EP (1) | EP2844647B1 (pl) |
JP (2) | JP6290186B2 (pl) |
KR (1) | KR102073181B1 (pl) |
CN (2) | CN108084138A (pl) |
AP (1) | AP3547A (pl) |
AU (1) | AU2013255469B2 (pl) |
BR (1) | BR112014027470A2 (pl) |
CA (1) | CA2871000C (pl) |
CL (1) | CL2014002986A1 (pl) |
CO (1) | CO7141413A2 (pl) |
CY (1) | CY1123456T1 (pl) |
EA (1) | EA032812B1 (pl) |
HK (1) | HK1203964A1 (pl) |
IL (1) | IL235181A (pl) |
MX (1) | MX365250B (pl) |
MY (1) | MY171207A (pl) |
NZ (1) | NZ701198A (pl) |
PH (1) | PH12014502453A1 (pl) |
PL (1) | PL2844647T3 (pl) |
RS (1) | RS61035B1 (pl) |
SG (1) | SG11201407184PA (pl) |
SI (1) | SI2844647T1 (pl) |
WO (1) | WO2013164801A1 (pl) |
ZA (1) | ZA201407769B (pl) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MY173795A (en) | 2009-11-05 | 2020-02-24 | Incozen Therapeutics Pvt Ltd | Novel benzopyran kinase modulators |
US10130635B2 (en) * | 2012-05-04 | 2018-11-20 | Rhizen Pharmaceuticals Sa | Process for preparation of optically pure and optionally substituted 2-(1-hydroxy-alkyl)-chromen-4-one derivatives and their use in preparing pharmaceuticals |
JP6290186B2 (ja) * | 2012-05-04 | 2018-03-07 | ライゼン・ファーマシューティカルズ・エスアー | 光学的に純粋で置換基を有していてもよい2−(1−ヒドロキシ−アルキル)クロメン−4−オン誘導体の調製方法および医薬品調製におけるそれらの使用 |
CN105358560B (zh) | 2013-06-07 | 2017-03-08 | 理森制药股份公司 | 双重选择性PI3δ和γ激酶抑制剂 |
DK3160968T3 (en) | 2014-06-27 | 2019-02-18 | Rhizen Pharmaceuticals S A | SUBSTITUTED CHROMINE DERIVATIVES AS SELECTIVE DOUBLE INHIBITORS OF PI3 DELTA AND GAMMA PROTEIN KINASES |
US9708348B2 (en) | 2014-10-03 | 2017-07-18 | Infinity Pharmaceuticals, Inc. | Trisubstituted bicyclic heterocyclic compounds with kinase activities and uses thereof |
US20180215727A1 (en) * | 2015-07-23 | 2018-08-02 | Pharmakea, Inc. | Lysyl oxidase-like 2 inhibitors and uses thereof |
JP2019508400A (ja) | 2016-02-09 | 2019-03-28 | ファーマケア,インク. | キノリノンリシルオキシダーゼ様2阻害剤とその使用 |
US10919914B2 (en) | 2016-06-08 | 2021-02-16 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
WO2023130334A1 (zh) * | 2022-01-07 | 2023-07-13 | 同润生物医药(上海)有限公司 | 一种色烯-4-酮化合物及其中间体的制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011055215A2 (en) * | 2009-11-05 | 2011-05-12 | Incozen Therapeutics Pvt. Ltd. | Novel kinase modulators |
WO2012151525A1 (en) * | 2011-05-04 | 2012-11-08 | Rhizen Pharmaceuticals Sa | Novel compounds as modulators of protein kinases |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS62201882A (ja) * | 1985-11-18 | 1987-09-05 | Yamanouchi Pharmaceut Co Ltd | イソフラボン誘導体 |
PE20060426A1 (es) * | 2004-06-02 | 2006-06-28 | Schering Corp | DERIVADOS DE ACIDO TARTARICO COMO INHIBIDORES DE MMPs, ADAMs, TACE Y TNF-alfa |
JP6290186B2 (ja) * | 2012-05-04 | 2018-03-07 | ライゼン・ファーマシューティカルズ・エスアー | 光学的に純粋で置換基を有していてもよい2−(1−ヒドロキシ−アルキル)クロメン−4−オン誘導体の調製方法および医薬品調製におけるそれらの使用 |
MY169987A (en) * | 2012-07-04 | 2019-06-19 | Rhizen Pharmaceuticals Sa | Selective pi3k delta inhibitors |
-
2013
- 2013-05-03 JP JP2015509560A patent/JP6290186B2/ja not_active Expired - Fee Related
- 2013-05-03 SG SG11201407184PA patent/SG11201407184PA/en unknown
- 2013-05-03 MX MX2014013426A patent/MX365250B/es active IP Right Grant
- 2013-05-03 BR BR112014027470A patent/BR112014027470A2/pt not_active Application Discontinuation
- 2013-05-03 RS RS20201267A patent/RS61035B1/sr unknown
- 2013-05-03 WO PCT/IB2013/053544 patent/WO2013164801A1/en active Application Filing
- 2013-05-03 EA EA201491818A patent/EA032812B1/ru unknown
- 2013-05-03 MY MYPI2014003098A patent/MY171207A/en unknown
- 2013-05-03 AU AU2013255469A patent/AU2013255469B2/en not_active Ceased
- 2013-05-03 EP EP13729095.3A patent/EP2844647B1/en active Active
- 2013-05-03 AP AP2014008087A patent/AP3547A/xx active
- 2013-05-03 US US14/398,902 patent/US9309216B2/en not_active Expired - Fee Related
- 2013-05-03 CN CN201810028555.5A patent/CN108084138A/zh active Pending
- 2013-05-03 CN CN201380023361.1A patent/CN104507922B/zh not_active Expired - Fee Related
- 2013-05-03 KR KR1020147034065A patent/KR102073181B1/ko active IP Right Grant
- 2013-05-03 NZ NZ701198A patent/NZ701198A/en not_active IP Right Cessation
- 2013-05-03 CA CA2871000A patent/CA2871000C/en not_active Expired - Fee Related
- 2013-05-03 SI SI201331803T patent/SI2844647T1/sl unknown
- 2013-05-03 PL PL13729095T patent/PL2844647T3/pl unknown
-
2014
- 2014-10-19 IL IL235181A patent/IL235181A/en active IP Right Grant
- 2014-10-24 ZA ZA2014/07769A patent/ZA201407769B/en unknown
- 2014-11-03 PH PH12014502453A patent/PH12014502453A1/en unknown
- 2014-11-04 CL CL2014002986A patent/CL2014002986A1/es unknown
- 2014-12-03 CO CO14266920A patent/CO7141413A2/es unknown
-
2015
- 2015-05-19 HK HK15104774.7A patent/HK1203964A1/xx unknown
-
2017
- 2017-12-14 JP JP2017239643A patent/JP2018039849A/ja active Pending
-
2020
- 2020-10-15 CY CY20201100974T patent/CY1123456T1/el unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011055215A2 (en) * | 2009-11-05 | 2011-05-12 | Incozen Therapeutics Pvt. Ltd. | Novel kinase modulators |
WO2012151525A1 (en) * | 2011-05-04 | 2012-11-08 | Rhizen Pharmaceuticals Sa | Novel compounds as modulators of protein kinases |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1203964A1 (en) | Process for preparation of optically pure and optionally substituted 2- (1 -hydroxy- alkyl) - chromen - 4 - one derivatives and their use in preparing pharmaceuticals 2-(1--)--4- | |
HK1198476A1 (zh) | 咪唑啉類衍生物、其製備方法及其在醫藥上的應用 | |
EP2834224A4 (en) | PROCESSES FOR THE PREPARATION OF BENZIMIDAZOLE DERIVATIVES AND SALTS THEREOF | |
HK1187335A1 (en) | Amino-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals 3-- | |
IL227711A0 (en) | Phenyl-isoxazole history and their preparation process | |
PL2726486T3 (pl) | Nowe estry n-acylowanych pochodnych aminokwasów i izosorbidu, sposób ich wytwarzania i ich zastosowanie w kosmetyku i jako leku | |
EP2865666A4 (en) | HEXAHYDROPENTALENE DERIVATIVES, METHOD OF MANUFACTURE AND USE IN MEDICINE | |
GB201218084D0 (en) | Novel compounds and methods for use in medicine | |
ZA201407214B (en) | Therapeutic preparation and process for preparing said therapeutic preparation | |
PL399613A1 (pl) | Pochodne estrów diarylowych kwasów 1-aminoalkanofosfonowych, sposób wytwarzania pochodnych estrów diarylowych kwasów 1-aminoalkanofosfonowych oraz ich zastosowanie | |
HRP20160687T1 (hr) | Supstituirani 2-(kroman-6-iloksi)tiazoli i njihova upotreba kao farmaceutska sredstva | |
HUE051029T2 (hu) | Eljárás optikailag tiszta és adott esetben szubsztituált 2-(1-hidroxi-alkil)-kromen-4-on származékok elõállítására és azok alkalmazása gyógyszerek elõállításában | |
IL238934A0 (en) | Methods for the preparation of phenyloxymethyl-nitro-imidazole derivatives and their use | |
IL231096A (en) | Theses are converted into 2- (novel-6-Iloxy) and used as pharmaceutical preparations | |
IL212725A (en) | Glycerol Preparation for Non-surgical Conjunctivochalysis | |
PL398945A1 (pl) | Chiralne symetryczne sole imidazoliowe, pochodne alkoholu nasyconego oraz sposób ich wytwarzania | |
PL398940A1 (pl) | Optycznie czynne symetryczne sole imidazolowe pochodne monoterpenowego alkoholu oraz sposób ich wytwarzania |